title: [Phase III study].
abstract: After a drug is found to have some minimal amount of activity in phase II study, the next step is to determine the effectiveness of compared new treatment to no-treatment or placebo, the best current standard therapy, and toxicity in phase III study. Phase III study is the most rigorous and extensive type of scientific clinical investigation of a new treatment. Accordingly, much of this issue is devoted to the principles of phase III study.
authors.affiliation: Dept. of Internal Medicine, National Kinki Central Hospital for Chest Disease, Sakai, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Furuse
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002985:Clinical Protocols; D017326:Clinical Trials, Phase III as Topic / Q000379:methods; D006801:Humans; D015993:Life Tables; D009369:Neoplasms / Q000188:drug therapy* / Q000401:mortality; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D011379:Prognosis; D011786:Quality Control
chemical_list: D000970:Antineoplastic Agents